NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.37−0.14 (-9.27%)
Close on Nov 18, 2026Market cap $2.52MP/E –Yield –
NeuroSense Therapeutics total assets
Total assets on the balance sheet at the end of each period.
NeuroSense Therapeutics's total assets was $896.00K at Jun 30, 2026. For fiscal 2025 it was $1.03M, down 77.5% from the year before. The highest annual figure on record is $11.43M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03M | -77.5% |
| FY2024 | Dec 31, 2024 | $4.58M | +43.6% |
| FY2023 | Dec 31, 2023 | $3.19M | -58.7% |
| FY2022 | Dec 31, 2022 | $7.72M | -32.5% |
| FY2021 | Dec 31, 2021 | $11.43M | +1367.4% |
| FY2020 | Dec 31, 2020 | $779.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $896.00K | -51.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.03M | -67.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.68M | -78.6% |
| Q4 FY2024 | Dec 31, 2024 | $4.58M | -40.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.84M | -83.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.19M | -72.1% |
| Q2 FY2023 | Jun 30, 2023 | $7.87M | +910.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.72M | – |
| Q2 FY2022 | Jun 30, 2022 | $11.45M | – |
| Q4 FY2021 | Dec 31, 2021 | $11.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $779.00K | – |
See a number that looks wrong?